Securities code: 300199 securities abbreviation: Hybio Pharmaceutical Co.Ltd(300199) Announcement No.: 2022-005
Hybio Pharmaceutical Co.Ltd(300199)
On the cancellation of pledge of some shares of controlling shareholders and actual controllers
Announcement on handling stock pledge repurchase business
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records
Contains, misleading statements or material omissions.
Special risk tips:
The controlling shareholder of Hybio Pharmaceutical Co.Ltd(300199) (hereinafter referred to as "the company" or " Hybio Pharmaceutical Co.Ltd(300199) ")
Mr. Zeng shaogui, the actual controller, has pledged 152590000 shares of the company, accounting for his shares of the company
The number proportion exceeds 80%, and Mr. Zeng Shaoqiang, the controlling shareholder and the person acting in concert with the actual controller, has cumulatively pledged the company
The number of shares is 106173648, accounting for more than 80% of the company's shares held by the controlling shareholder and the actual
Mr. Zeng Shaobin, the person acting in concert of the controller, has pledged 25900000 shares of the company, accounting for the total number of shares held by him
The proportion of the company's shares exceeds 80%. Please pay attention to the investment risk.
Recently Hybio Pharmaceutical Co.Ltd(300199) received a notice from Mr. Zeng shaogui, the controlling shareholder and actual controller of the company
Handled the pledge cancellation and pledge repurchase of some shares. The relevant information is hereby announced as follows:
1、 Basic information of this pledge cancellation
Whether it is the shareholder controlling the released shares or whether the Pledged Shares are released on the pledge start date, and whether the pledge release date accounts for the largest number of shares (shares) of the company except the pledge name It refers to the proportion of the total share capital of the pledgee in its East and its first share sale proportion, and the proportion of the person holding the shares to act
Zeng shaogui is 23900000 no 2021.1.18 2022.1.13 Shenzhen guarantee Group Co., Ltd. 2.61% 15.56%
Total 23900000 - 2.61%-
2、 Pledge of shareholders' shares
Is this quality control
Whether the number of shareholders or pledged shares is released on the pledge start date, accounting for the largest share (share) of the company's pledged name is the total share capital of the pledgee on the deadline date, and the proportion of tudong and its first sale shares
To moving
Go through the formalities of cancelling the 2.61% and 15.56% capital of Shenzhen guarantee group Rongzeng shaogui is 23900000 or not, 2022.1.13 pledge registration Co., Ltd
Total 23900000 - 2.61% --
3、 Cumulative pledge of shareholders' shares
As of the disclosure date of this announcement, the shares held by the controlling shareholders, actual controllers and persons acting in concert of the company have been pledged
The situation is as follows:
Pledged but not Pledged Shares: shares held by the current pledge
The number of shares held by shareholders is higher than the total number of companies held by pledge before pledge
Pledged shares pledged shares accounted for pledged shares accounted for non pledged shares accounted for non weighed (shares) number of shares share capital shares limited to shares
Proportion sale and frozen pledge sale and frozen pledge (shares) (shares) number of shares settled proportion number of shares settled proportion (shares) (shares)
Zeng shaogui 153606 16.75% 152590 152590 99.34 16.64 114206 74.85
,167 ,000 ,000 % % ,986 % 997,639 0.65%
Zeng Shaoqiang 107047 11.67% 106173 106173 99.18 11.58 80183, 75.52
,840 ,648 ,648 % % 302 % 102,578 0.10%
Zeng Shaobin 28956, 3.16%, 25900, 25900, 89.45, 21710, 83.83
024 000 000 % 2.82% 994 % 6,024 0.02%
Total 289610 31.58% 284663 284663 98.29 31.05 216101 1106,2
,031 ,648 ,648 % % ,282 - 41 -
4、 Other information
1. Controlling shareholder and actual controller Mr. Zeng shaogui and persons acting in concert Mr. Zeng Shaoqiang and Mr. Zeng Shaobin
The Pledged Shares are mainly used to repay the pledged loans in the early stage, and the repayment funds are expected to come from self owned and self raised funds.
2. Controlling shareholder and actual controller Mr. Zeng shaogui and persons acting in concert Mr. Zeng Shaoqiang and Mr. Zeng Shaobin
The cumulative number of pledged shares due within the next six months is 29.4536 million, accounting for 20% of the total shares of the company
10.17%, accounting for 3.21% of the total share capital of the company, and the corresponding financing amount is 115 million yuan; Pledge due within the next year
The cumulative number of shares is 284663600, accounting for 98.29% of the total shares of the company, accounting for the total shares of the company
This is 31.05%, and the corresponding financing amount is 1315.4 million yuan.
Personal credit and financial status of controlling shareholders, actual controllers and persons acting in concert as of the disclosure date of the announcement
The business is in good condition and has the corresponding capital repayment ability. It is expected that the sources of repayment funds in the future will be self owned and self raised funds.
There is no risk of closing positions or being forcibly transferred.
3. The controlling shareholders, actual controllers and persons acting in concert do not infringe on the interests of the listed company such as occupation of non operating funds and illegal guarantee.
4. The above actions will not lead to the change of the company's actual control, and will not have an impact on the company's production and operation and corporate governance. At present, Mr. Zeng shaogui has no risk of closing positions or being forced to close positions. If the above risks occur in the future, it will take measures including but not limited to early repurchase and supplement of pledged underlying securities. The company will continue to pay attention to its pledge and pledge risk, strictly abide by relevant regulations and timely perform the obligation of information disclosure. Please pay attention to the investment risk.
It is hereby announced.
Hybio Pharmaceutical Co.Ltd(300199) board of directors January 18, 2022
